Trials / Sponsors / Curegenix Inc.
Curegenix Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma | Phase 1 | 2017-06-17 |
| Unknown | CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Su Solid Tumors, GI Cancer | Phase 1 | 2016-02-01 |